Pharmatrends 2020: the future of tech lies in integrated platforms

Human Data Science or the use of artificial intelligence and machine learning applied to big data. Moreover, it mediated by human expertise, to find new governance solutions in the health and pharmaceutical fields.

This is the theme of Pharmatrends 2020. The annual conference organized by Iqvia: “Healthcare is significantly further behind in the development of data science,” – admits Carlo Salvioni, vice president of Iqvia Italy.

In the adoption of AI and new generation technologies, we are adding the ninth national industry out of thirteen. In addition, those who approach this new science focuses mainly on data cleaning (80%). And, does not do analysis to capture insights from which to draw innovative proposals.

The examination of the numbers

This delay also emerges from the examination of the numbers: taking the aggregate data of the 15 most important pharmaceutical companies in the period 2013-2019, against an increase in sales of 10% in 6 years, expenditure on research and development increased by 33%. While returns on R&D investment have fallen by more than 20%.

Salvioni continues: “This is leading to delays in clinical trials, with more than 80% of companies failing to meet the set deadlines, for a further increase in costs. The solution? According to Iqvia, we need to start thinking in terms of the ecosystem, i.e. we need a shared environment in which to connect all the components of the healthcare and pharmaceutical supply chain, from hospitals to industries.

“In order to grow and find solutions that create value, we need to bring together, through integrated technology platforms, the different compartments of the health world, from clinical to real-world, from compliance to commercial: this is a need for both public and private structures”.

Integrated technology platforms

“In order to grow and find solutions that create value, we need to bring together, through integrated technology platforms, the different compartments of the health world, from clinical to real-world, from compliance to commercial: this is a need for both public and private structures”.

Incorporating pharmaceutical data

Developing human data science means, first of all, improving people’s lives. The confirmation comes, among others, from Francesca Dominici, co-director of the Data Science Initiative of Harvard University and keynote speaker of the event Iqvia.

“With the data platform, incorporating data from different sources, you can achieve very important results, such as establishing the impact of pollution on health, which we have done by taking as a sample the population of the United States.

The result was a concrete intervention by political institutions to lower the level of pollution in cities. Still, data science allows you to measure the effect of a drug, considering the environment and lifestyles.

 —

(Featured Image By Hitesh Choudhary)

First published in mark-up, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.